Related Experiment Videos
Ocular neovascularization in patients with uveitis
1Francis I. Proctor Foundation, UCSF, Medical Center 94143, USA.
International Ophthalmology Clinics
|May 3, 2000
Summary
Neovascularization, a rare but serious complication of uveitis, often affects the retina and optic disk. Management involves corticosteroids, with laser photocoagulation or surgery considered for refractory cases.
Area of Science:
- Ophthalmology
- Vascular Biology
Background:
- Neovascularization is an infrequent but serious complication of uveitis.
- It most commonly affects the retina and optic disk, but can also arise from the iris, ciliary body, and choroid.
- Clinical identification may require fluorescein angiography or ultrasound biomicroscopy (UBM).
Purpose of the Study:
- To review the clinical presentation, diagnosis, and management of neovascularization in uveitis.
- To highlight the role of inflammation severity and retinal nonperfusion in disease development.
- To outline treatment strategies including corticosteroids, laser photocoagulation, and surgical intervention.
Main Methods:
- Review of clinical findings and diagnostic modalities for uveitic neovascularization.
- Discussion of experimental and clinical factors influencing neovascularization.
- Analysis of treatment outcomes for various therapeutic interventions.
Main Results:
- Uveitic neovascularization is directly influenced by inflammation severity and retinal nonperfusion.
- Corticosteroids are the primary treatment for most patients.
- Laser photocoagulation and surgical excision are reserved for specific, refractory cases.
Conclusions:
- Early identification and prompt treatment are crucial for managing neovascularization in uveitis.
- Corticosteroid therapy is the cornerstone of treatment.
- Advanced therapies like laser photocoagulation and surgery have specific indications.